Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer
NCT05348668
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
78
Enrollment
OTHER_GOV
Sponsor class
Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG:
Hybrid dose-fraction Radiotherapy combined with immune checkpoint inhibitors
Sponsor
Anhui Provincial Hospital